- Research works
- 26 ▲ 284% vs 2013–17
- Citations
- 393 15.3 per fractional work
- Top-10% rate
- 9.5% record average 16.5%
- Open access
- 49% world 28%
Not ranked overall: Pulmonary Fibrosis Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.4×. Every wedge is a field page.
Which keywords describe research at Pulmonary Fibrosis Foundation?
By fractional works in all years, weighted toward what it does more of than the world: Fibrosis, TGF-ß, Interstitial Lung Disease, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, Myofibroblast, Diagnosis and Management.
- Quality of Life
- spirometry
- COPD
- Epidemiology
- Treatment
- Sarcoidosis
- Management
- Myofibroblast
- TGF-ß
- Epithelial-Mesenchymal Transition
- Fibrosis
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Diagnosis
- Cardiac
- Clinical Trials
- Autoantibodies
- Global Burden
- Immunosuppressive Therapy
- Microbiota
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Fibrosis6▲ 126×2 topics
- Epithelial-Mesenchymal Transition6▲ 257×2 topics
- Interstitial Lung Disease6▲ 406×2 topics
- TGF-ß6▲ 130×2 topics
- Idiopathic Pulmonary Fibrosis6▲ 562×1 topic
- Myofibroblast6▲ 562×1 topic
- Diagnosis4▲ 14×6 topics
- Management4▲ 18×5 topics
- Cardiac2▲ 485×1 topic
- Sarcoidosis2▲ 485×1 topic
- Clinical Trials1▲ 9.0×5 topics
- Treatment1▲ 4.2×6 topics
- Autoantibodies1▲ 20×3 topics
- Epidemiology1▲ 1.20×11 topics
- Global Burden1▲ 8.7×2 topics
- COPD1▲ 67×1 topic
- Immunosuppressive Therapy1▲ 21×3 topics
- spirometry1▲ 67×1 topic
- Microbiota1▲ 17×2 topics
- Quality of Life1▲ 2.9×5 topics
Which research topics does Pulmonary Fibrosis Foundation publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Sarcoidosis and Beryllium Toxicity Research, Pharmaceutical industry and healthcare and Systemic Sclerosis and Related Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
- 2 Sarcoidosis and Beryllium Toxicity Research Physiology 1 works
- 3 Pharmaceutical industry and healthcare Pharmacology 0 works
- 4 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
- 5 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
- 6 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
- 7 Eosinophilic Esophagitis Surgery 0 works
- 8 Nursing education and management Research and Theory 0 works
- 9 Education Systems and Policy Education 0 works
- 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pulmonary Fibrosis Foundation's research output changed?
Output in 2018–2022 was 284% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- University of Chicago
- University of Illinois Chicago
- Loyola University Chicago
- Rush University Medical Center
- Illinois Institute of Technology
- DePaul University
- Experimental Station
- Boeing (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.